Home » Biogen Touts MS Drug as Cost Effective
Biogen Touts MS Drug as Cost Effective
Drug maker Biogen Idec Inc. said Friday a one-year study of its multiple sclerosis
drug Avonex shows it is more cost-effective than similar treatments.
BusinessWeek
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May